BOWIE, Md., Jan. 09, 2017 -- Inovalon (Nasdaq:INOV), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based models across the healthcare ecosystem, today announced a multi-year extension of its partnership with Anthem, Inc. (NYSE:ANTM), one of the nation’s leading health benefits companies.
The collaboration enables Inovalon and Anthem to leverage the strengths of the two organizations and years of data from working together to maximize value and impact to consumers. Applying an integrated set of Inovalon’s modular platform capabilities in combination with Anthem’s internal capabilities, the partnership achieves a highly efficient, best-practices integration of data-driven, value-based technologies.
The Inovalon and Anthem collaboration covers Anthem’s commercial health insurance, Medicare and Medicaid businesses. As part of the extended collaboration, Anthem will begin implementation of Inovalon’s Data Diagnostics®, a point-of-care healthcare analytics technology delivered in collaboration with Quest Diagnostics (NYSE:DGX).
About Inovalon
Inovalon is a leading technology company providing cloud-based platforms empowering a data-driven transformation from volume-based to value-based models throughout the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and industry-leading subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon's unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action®.” Providing technology that supports nearly 500 healthcare organizations, Inovalon's platforms are informed by data pertaining to more than 837,000 physicians, 354,000 clinical facilities, and more than 139 million Americans. For more information, visit www.inovalon.com.
Contacts: Kim Collins [email protected] (301) 809-4000 X-1473 George Price (Investors) [email protected] (301) 809-4000 X-1190


Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 



